Financials in USD. Standardized financial statements.
A compact view of how American Oriental Bioengineering, Inc. turns revenue into operating income and net income.
| Metric | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $145.10M | $212.69M | $305.94M | $296.15M | $264.64M | $160.48M | $110.18M | $54.73M | $31.97M | $20.86M |
| Revenue Growth? | -31.8% | -30.5% | +3.3% | +11.9% | +64.9% | +45.7% | +101.3% | +71.2% | +53.2% | 0.0% |
| Cost of Revenue? | $100.74M | $112.94M | $148.19M | $129.37M | $91.03M | $49.36M | $38.32M | $19.61M | $11.27M | $7.51M |
| Gross Profit? | $44.36M | $99.75M | $157.76M | $166.78M | $173.61M | $111.12M | $71.86M | $35.13M | $20.70M | $13.35M |
| Gross Margin? | +30.6% | +46.9% | +51.6% | +56.3% | +65.6% | +69.2% | +65.2% | +64.2% | +64.8% | +64.0% |
| Operating Expenses? | $130.69M | $142.87M | $127.39M | $108.02M | $97.03M | $58.89M | $35.49M | $16.79M | $10.65M | $7.62M |
| Operating Income? | -$54.97M | -$3.54M | $30.37M | $58.76M | $63.49M | $52.23M | $36.38M | $18.34M | $10.04M | $5.70M |
| EBITDA? | -$39.64M | -$48.78M | $42.00M | $72.70M | $72.21M | $56.97M | $39.59M | $20.53M | $11.91M | $7.34M |
| Income Before Tax | -$57.50M | -$67.86M | $23.39M | $54.52M | $59.72M | $52.34M | $36.62M | $17.83M | $9.99M | $5.74M |
| Income Tax Expense | $2.22M | $635,053 | $9.34M | $13.22M | $12.73M | $9.05M | $7.42M | $4.40M | $2.22M | $1.14M |
| Net Income? | -$59.71M | -$68.49M | $14.09M | $41.42M | $47.06M | $43.29M | $29.20M | $13.43M | $7.77M | $4.60M |
| EPS? | $-781.24 | $-901.80 | $190.38 | $1112.22 | $621.24 | $621.24 | $470.94 | $310.62 | $230.46 | $150.30 |
| Diluted EPS? | $-781.24 | $-901.80 | $185.37 | $1062.12 | $611.22 | $611.22 | $460.92 | $310.62 | $230.46 | $150.30 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality